Galapagos obtains U.S. patent for technique to screen gene function

By Jennifer Chiou

New York, Oct. 7 - Galapagos NV announced it received a third U.S. patent for its "high throughput screening of gene function using adenoviral libraries for functional genomics applications."

This patent protects the method of determining the function of a nucleic acid and extends the patent life until 2019.

The first two patents claimed the adenoviral library and its production.

Based in Mechelen, Belgium, Galapagos is focused on drug discovery for the treatment of bone and joint diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.